These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28159016)

  • 1. α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosis.
    Kanno Y; Shu E; Kanoh H; Matsuda A; Seishima M
    Arthritis Res Ther; 2017 Feb; 19(1):22. PubMed ID: 28159016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F(2α) synthesis through adipose triglyceride lipase/calcium-independent phospholipase A(2).
    Kanno Y; Kawashita E; Kokado A; Okada K; Ueshima S; Matsuo O; Matsuno H
    Arthritis Rheum; 2013 Feb; 65(2):492-502. PubMed ID: 23124680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Antifibrotic Effect of α2AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic Sclerosis.
    Kanno Y; Shu E; Kanoh H; Seishima M
    J Invest Dermatol; 2016 Apr; 136(4):762-769. PubMed ID: 26743600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-30c attenuates fibrosis progression and vascular dysfunction in systemic sclerosis model mice.
    Kanno Y; Shu E; Niwa H; Seishima M; Ozaki KI
    Mol Biol Rep; 2021 Apr; 48(4):3431-3437. PubMed ID: 33913094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in matrix metalloproteinase‑3 activity in systemic sclerosis fibroblasts causes α2‑antiplasmin and extracellular matrix deposition, and contributes to fibrosis development.
    Niwa H; Kanno Y; Shu E; Seishima M
    Mol Med Rep; 2020 Oct; 22(4):3001-3007. PubMed ID: 32945390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis.
    Kanno Y
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30709025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatively activated macrophages are associated with the α2AP production that occurs with the development of dermal fibrosis : The role of alternatively activated macrophages on the development of fibrosis.
    Kanno Y; Shu E; Niwa H; Kanoh H; Seishima M
    Arthritis Res Ther; 2020 Apr; 22(1):76. PubMed ID: 32272967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.
    Mazzotta C; Manetti M; Rosa I; Romano E; Blagojevic J; Bellando-Randone S; Bruni C; Lepri G; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Res Ther; 2017 Feb; 19(1):27. PubMed ID: 28183357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis.
    Maurer B; Distler A; Suliman YA; Gay RE; Michel BA; Gay S; Distler JH; Distler O
    Ann Rheum Dis; 2014 Oct; 73(10):1880-7. PubMed ID: 23918036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha2-antiplasmin is associated with the progression of fibrosis.
    Kanno Y; Kawashita E; Minamida M; Kaneiwa A; Okada K; Ueshima S; Matsuo O; Matsuno H
    Am J Pathol; 2010 Jan; 176(1):238-45. PubMed ID: 20008146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α2-antiplasmin positively regulates endothelial-to-mesenchymal transition and fibrosis progression in diabetic nephropathy.
    Kanno Y; Hirota M; Matsuo O; Ozaki KI
    Mol Biol Rep; 2022 Jan; 49(1):205-215. PubMed ID: 34709571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.
    Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-induced interstitial transformation of microvascular endothelial cells by mediating HIF-1α/VEGF signaling in systemic sclerosis.
    Mao J; Liu J; Zhou M; Wang G; Xiong X; Deng Y
    PLoS One; 2022; 17(3):e0263369. PubMed ID: 35231032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.
    Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
    Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein-7 inhibits endothelial-to-mesenchymal transition in primary human umbilical vein endothelial cells and mouse model of systemic sclerosis via Akt/mTOR/p70S6K pathway.
    Shen C; Jiang Y; Li Q; Liu C; Hu F; Li M
    J Dermatol Sci; 2021 Aug; 103(2):82-92. PubMed ID: 34266726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of human-induced pluripotent stem cell-derived endothelial cells in a bleomycin-induced scleroderma mouse model.
    Azhdari M; Baghaban-Eslaminejad M; Baharvand H; Aghdami N
    Stem Cell Res; 2013 May; 10(3):288-300. PubMed ID: 23396195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor β in the skin of mice with scleroderma-like features and prevents the development of the disease.
    Kavian N; Servettaz A; Marut W; Nicco C; Chéreau C; Weill B; Batteux F
    Arthritis Rheum; 2012 Jun; 64(6):1990-2000. PubMed ID: 22213155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.